340314940	340314940	CD	B-NP	O
|	|	NN	I-NP	O
NRAGH	NRAGH	NN	I-NP	O
|	|	NN	I-NP	O
43292881	43292881	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1034838	1034838	CD	B-NP	O
|	|	CC	I-NP	O
7/24/2005	7/24/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
mitral	mitral	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/12/2005	11/12/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/16/2005	7/16/2005	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-NP	O
DOWERY	DOWERY	NN	I-NP	O
,	,	,	O	O
RAYMUNDO	RAYMUNDO	NNP	B-NP	O
DOUGLAS	DOUGLAS	NNP	I-NP	O
335-52-88-2	335-52-88-2	CD	I-NP	O
Clear	Clear	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
11/4/05	11/4/05	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CHRISTI	CHRISTI	NNP	B-NP	O
,	,	,	O	O
ALLAN	ALLAN	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
VITAMIN	VITAMIN	NNP	B-NP	O
C	C	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASCORBIC	ASCORBIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ECASA	ECASA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/22/05	10/22/05	CD	B-NP	O
by	by	IN	B-PP	O
SCHLOSSMAN	SCHLOSSMAN	NNP	B-NP	O
,	,	,	O	O
EDMOND	EDMOND	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
VITAMIN	VITAMIN	NNP	B-NP	O
E	E	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TOCOPHEROL-DL-ALPHA	TOCOPHEROL-DL-ALPHA	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
400	400	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
BISOPROLOL	BISOPROLOL	NNP	I-NP	O
FUMARATE	FUMARATE	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/22/05	10/22/05	CD	B-NP	O
by	by	IN	B-PP	O
OVERBECK	OVERBECK	NNP	B-NP	O
,	,	,	O	O
NATHANAEL	NATHANAEL	NNP	B-NP	O
O.	O.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TIAZAC	TIAZAC	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
43369408	43369408	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
BISOPROLOL	BISOPROLOL	NNP	B-NP	O
FUMARATE	FUMARATE	NNP	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
DOFETILIDE	DOFETILIDE	NN	I-NP	O
500	500	CD	B-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/20	9/20	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/22/05	10/22/05	CD	B-NP	O
by	by	IN	B-PP	O
VAGLE	VAGLE	NNP	B-NP	O
,	,	,	O	O
WILSON	WILSON	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
METFORMIN	METFORMIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
86609782	86609782	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DOFETILIDE	DOFETILIDE	NNP	B-NP	O
&	&	CC	I-NP	O
METFORMIN	METFORMIN	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/22/05	10/22/05	CD	B-NP	O
by	by	IN	B-PP	O
MANCUSI	MANCUSI	NNP	B-NP	O
,	,	,	O	O
WADE	WADE	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METFORMIN	METFORMIN	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
DOFETILIDE	DOFETILIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METFORMIN	METFORMIN	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
DOFETILIDE	DOFETILIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	NNS	B-NP	O
,	,	,	O	O
monitoring	monitor	VBG	B-VP	O
COUMADIN	COUMADIN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/20	9/20	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/22/05	10/22/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
COUMADIN	COUMADIN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
12	12	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/20	9/20	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
Friday	Friday	NNP	B-NP	O
,	,	,	O	O
Monday	Monday	NNP	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/22/05	10/22/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
LIPITOR	LIPITOR	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ATORVASTATIN	ATORVASTATIN	NN	I-NP	I-protein
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/22/05	10/22/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	NNS	B-NP	O
,	,	,	O	O
monitored	monitor	VBD	B-VP	O
GLUCOVANCE	GLUCOVANCE	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GLYBURIDE/METFORMIN	GLYBURIDE/METFORMIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
/	/	SYM	B-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Take	Take	VB	B-VP	O
1.5	1.5	CD	B-NP	O
pills	pill	NNS	I-NP	O
in	in	IN	B-PP	O
morning	morning	NN	B-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
pills	pill	NNS	I-NP	O
in	in	IN	B-PP	O
evening	evening	NN	B-NP	O
as	as	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
doing	do	VBG	I-VP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/22/05	10/22/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DOFETILIDE	DOFETILIDE	NNP	B-NP	O
&	&	CC	I-NP	O
METFORMIN	METFORMIN	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DOFETILIDE	DOFETILIDE	NNP	B-NP	O
&	&	CC	I-NP	O
METFORMIN	METFORMIN	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	NNS	B-NP	O
,	,	,	O	O
monitored	monitor	VBD	B-VP	O
DILTIAZEM	DILTIAZEM	NNP	B-NP	O
CD	CD	NNP	I-NP	O
120	120	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/22/05	10/22/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
BISOPROLOL	BISOPROLOL	NNP	B-NP	O
FUMARATE	FUMARATE	NNP	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	NNS	B-NP	O
,	,	,	O	O
monitored	monitor	VBD	B-VP	O
LASIX	LASIX	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Pontiff	Pontiff	NNP	I-NP	O
,	,	,	O	O
call	call	NN	B-NP	O
for	for	IN	B-PP	O
appointment	appointment	NN	B-NP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
5/5/05	5/5/05	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
30	30	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
anticogulation	anticogulation	NN	B-NP	O
clinic	clinic	NN	I-NP	O
395-5254	395-5254	CD	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NN	B-NP	O
,	,	,	O	O
Codeine	Codeine	NN	B-NP	O
,	,	,	O	O
PROCAINAMIDE	PROCAINAMIDE	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
mitral	mitral	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
mitral	mitral	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HYPERCHOLESTEROLEMIA	HYPERCHOLESTEROLEMIA	NNP	I-NP	O
PAF	PAF	NNP	I-NP	B-protein
RF	RF	NNP	I-NP	O
REFLUX	REFLUX	NNP	I-NP	O
ESOPHAGITIS	ESOPHAGITIS	NNP	I-NP	O
OPERATIONS	OPERATIONS	NNPS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNPS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Diuresis	Diuresis	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
56	56	CD	B-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
MR	MR	NN	B-NP	B-protein
,	,	,	O	O
PAF	PAF	NN	B-NP	B-protein
,	,	,	O	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	O
.	.	.	O	O

HPI	HPI	LS	B-LST	B-cell_type
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
USOH	USOH	NN	B-NP	O
until	until	IN	B-PP	O
5	5	CD	B-NP	O
d	d	NN	I-NP	O
PTA	PTA	NN	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
went	go	VBD	B-VP	O
into	into	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
PAF	PAF	NN	B-NP	B-protein
and	and	CC	B-PP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
episodes	episode	NNS	I-NP	O
tends	tend	VBZ	B-VP	O
to	to	TO	I-VP	O
feel	feel	VB	I-VP	O
very	very	RB	B-ADVP	O
poorly	poorly	RB	I-ADVP	O
with	with	IN	B-PP	O
fatigue	fatigue	NN	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
DOE	DOE	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
cardioverted	cardioverte	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
NSR	NSR	NN	B-NP	B-protein
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
went	go	VBD	B-VP	O
home	home	NN	B-NP	O
feeling	feeling	NN	I-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

Overnight	Overnight	RB	B-ADVP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
awoke	awake	VBD	B-VP	O
with	with	IN	B-PP	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
audible	audible	JJ	B-NP	O
wheeze	wheeze	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
never	never	RB	I-VP	O
having	have	VBG	I-VP	O
had	have	VBD	I-VP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
episode	episode	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
note	note	VB	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
having	have	VBG	I-VP	O
some	some	DT	B-NP	O
increasing	increase	VBG	I-NP	O
exertional	exertional	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
few	few	JJ	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
N/V	N/V	NN	B-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
never	never	RB	I-VP	O
had	have	VBN	I-VP	O
peripheral	peripheral	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
VRMC	VRMC	NN	B-NP	O
ED	ED	NN	I-NP	O
after	after	IN	B-PP	O
discussion	discussion	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Elvin	Elvin	NNP	I-NP	O
Lekey	Lekey	NNP	I-NP	O
In	In	NNP	I-NP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
,	,	,	O	O
vitals	vital	NNS	B-NP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
HR	HR	NN	B-NP	B-protein
70s-80s	70s-80	NNS	I-NP	I-protein
and	and	CC	O	O
BP	BP	NN	B-NP	B-protein
133/64	133/64	CD	I-NP	I-protein
.	.	.	O	O

SaO2	SaO2	NN	B-NP	O
96-98	96-98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
MR	MR	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	O
mod	mod	NN	I-NP	O
on	on	IN	B-PP	O
echo	echo	JJ	B-NP	O
2002	2002	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
rheumatic	rheumatic	JJ	B-NP	O
heart	heart	NN	I-NP	O
dz	dz	NN	I-NP	O
as	as	IN	B-PP	O
child	child	NN	B-NP	O
.	.	.	O	O

Nl	Nl	NNP	B-NP	B-cell_type
LV	LV	NNP	I-NP	O
fxn	fxn	NN	I-NP	O
echo	echo	NN	I-NP	O
2002	2002	CD	I-NP	O
.	.	.	O	O

PAF	PAF	NN	B-NP	B-protein
,	,	,	I-NP	O
s/p	s/p	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
cardioversions	cardioversion	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

DM	DM	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
endocarditis	endocarditis	NN	B-NP	O
1967	1967	CD	I-NP	O
,	,	,	O	O
TAH/BSO	TAH/BSO	NN	B-NP	B-protein
,	,	,	O	O
hx	hx	NN	B-NP	O
procainamide-induced	procainamide-induced	JJ	I-NP	O
SLE	SLE	NN	I-NP	O
.	.	.	O	O

MEDS	MEDS	NNS	B-NP	O
:	:	:	O	O
Glucovance	Glucovance	NN	B-NP	O
1.5	1.5	CD	I-NP	O
q	q	NN	I-NP	O
am	am	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
qpm	qpm	NN	I-NP	O
.	.	.	O	O

Bisoprolol10	Bisoprolol10	NN	B-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
6/24	6/24	CD	I-NP	O
M	M	NN	I-NP	O
and	and	CC	O	O
F.	F.	NNP	B-NP	O
Dofetilide	Dofetilide	NNP	I-NP	O
.5	.5	CD	I-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

lipitor	lipitor	NN	B-NP	O
40	40	CD	I-NP	O
.	.	.	O	O

Dilt	Dilt	JJ	B-NP	O
CR	CR	JJ	I-NP	O
120qd	120qd	NN	I-NP	O
.	.	.	O	O

ASA	ASA	NN	B-NP	O
81	81	CD	I-NP	O
.	.	.	O	O

Garlic	Garlic	NNP	B-NP	O
,	,	,	O	O
Vit	Vit	NNP	B-NP	B-protein
C	C	NNP	I-NP	I-protein
,	,	,	O	O
Vit	Vit	NNP	B-NP	O
D.	D.	NNP	I-NP	O
SH	SH	NNP	I-NP	O
:	:	:	O	O
tob	tob	NN	B-NP	O
quit	quit	NN	I-NP	O
age	age	NN	I-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
etoh	etoh	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
minister	minister	NN	I-NP	O
in	in	IN	B-PP	O
non-denominational	non-denominational	JJ	B-NP	O
church	church	NN	I-NP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
:	:	:	O	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
pleasant	pleasant	JJ	I-NP	O
woman	woman	NN	I-NP	O
in	in	IN	B-PP	O
NAD	NAD	NN	B-NP	O
.	.	.	O	O

Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
MR	MR	NN	B-NP	B-protein
murmur	murmur	NN	I-NP	O
apex	apex	NN	I-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
axilla	axilla	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
at	at	IN	B-PP	O
angle	angle	NN	B-NP	O
of	of	IN	B-PP	O
jaw	jaw	NN	B-NP	B-protein
.	.	.	O	O

DP	DP	NN	B-NP	O
pulses	pulse	VBZ	B-VP	O
palpable	palpable	JJ	B-ADJP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	B-protein
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
3.8	3.8	CD	I-NP	I-protein
,	,	,	O	O
BNP	BNP	NN	B-NP	B-protein
311	311	CD	I-NP	I-protein
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
,	,	,	O	O
LAE	LAE	NN	B-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
enlarged	enlarge	VBN	B-NP	O
heart	heart	NN	I-NP	O
,	,	,	O	O
sm	sm	NN	B-NP	O
L	L	NN	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O
?	?	.	O	O

increased	increase	VBN	B-NP	O
vascular	vascular	JJ	I-NP	O
prominence	prominence	NN	I-NP	O
.	.	.	O	O

ECHO	ECHO	NN	B-NP	O
:	:	:	O	O
Day	Day	NN	B-NP	O
PTA	PTA	NN	I-NP	O
,	,	,	O	O
final	final	JJ	B-NP	O
report	report	NN	I-NP	O
pending	pending	NN	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
verbal	verbal	JJ	B-NP	O
report	report	NN	I-NP	O
shows	show	VBZ	B-VP	O
severe	severe	JJ	B-NP	O
MR	MR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
moderate	moderate	JJ	B-ADJP	O
on	on	IN	B-PP	O
past	past	JJ	B-NP	B-protein
studies	study	NNS	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
56	56	CD	B-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
MR	MR	NN	B-NP	B-protein
and	and	CC	I-NP	O
PAF	PAF	NN	I-NP	B-protein
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
failue	failue	VBP	B-VP	O
most	most	RBS	B-ADJP	O
likely	likely	RB	I-ADJP	O
related	relate	VBN	I-ADJP	O
to	to	TO	B-PP	O
chronic	chronic	JJ	B-NP	O
worsening	worsen	VBG	I-NP	O
MR.	MR.	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
**	**	SYM	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
I	I	PRP	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
ichemia	ichemia	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
known	known	JJ	I-NP	O
CAD	CAD	NN	I-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-VP	O
on	on	IN	B-PP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
.	.	.	O	O

P	P	NN	B-NP	O
:	:	:	O	O
MR	MR	NN	B-NP	B-protein
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
RHD	RHD	NN	B-NP	B-protein
.	.	.	O	O

Current	Current	JJ	B-NP	O
sx	sx	NN	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
likely	likely	RB	B-ADJP	O
related	related	JJ	I-ADJP	O
to	to	TO	B-PP	O
worsening	worsen	VBG	B-VP	O
MR.	MR.	NNP	B-NP	O
Ms.	Ms.	NNP	I-NP	O
Malawy	Malawy	NNP	I-NP	O
responded	respond	VBD	B-VP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
to	to	TO	B-PP	O
diuresis	diuresis	NN	B-NP	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	I-NP	O
cough	cough	NN	I-NP	O
and	and	CC	I-NP	O
wheeze	wheeze	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
standing	standing	NN	I-NP	O
dose	dose	NN	I-NP	O
40	40	CD	I-NP	O
po	po	NN	I-NP	O
lasix	lasix	NN	I-NP	O
qd	qd	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Reaver	Reaver	NNP	I-NP	O
for	for	IN	B-PP	O
discussion	discussion	NN	B-NP	O
of	of	IN	B-PP	O
future	future	JJ	B-NP	O
management	management	NN	I-NP	O
options	option	NNS	I-NP	O
including	include	VBG	B-PP	O
MVR	MVR	NNP	B-NP	O
R	R	NNP	I-NP	O
:	:	:	O	O
PAF	PAF	NN	B-NP	B-protein
,	,	,	O	O
NSR	NSR	NN	B-NP	B-protein
at	at	IN	B-PP	O
present	present	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
weight	weight	NN	I-NP	I-protein
4/25	4/25	CD	I-NP	I-protein
is	be	VBZ	B-VP	O
114kg	114kg	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
anti-arrhythmic	anti-arrhythmic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

coumadin	coumadin	NN	B-NP	O
held	hold	VBN	B-VP	O
for	for	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
INR	INR	NN	I-NP	O
1/1	1/1	CD	I-NP	O
**	**	SYM	I-NP	O
ENDOCRINE	ENDOCRINE	NN	I-NP	O
:	:	:	O	O
DM	DM	NN	B-NP	O
Type	Type	NN	I-NP	O
II	II	CD	I-NP	O
.	.	.	O	O

Home	Home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
held	hold	VBN	B-VP	O
in	in	IN	B-PP	O
favor	favor	NN	B-NP	O
of	of	IN	B-PP	O
lantus	lantus	NN	B-NP	B-protein
basal	basal	JJ	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
and	and	CC	I-NP	O
novolog	novolog	NN	I-NP	O
ss	ss	NN	I-NP	O
for	for	IN	B-PP	O
tighter	tight	JJR	B-NP	O
glycemic	glycemic	JJ	I-NP	O
control	control	NN	I-NP	O
in-house	in-house	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

**	**	SYM	B-NP	O
FEN	FEN	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gm	gm	NN	I-NP	O
Na	Na	NN	I-NP	O
,	,	,	O	O
carbohydrate	carbohydrate	NN	B-NP	O
controlled	control	VBN	B-VP	O
.	.	.	O	O

**	**	SYM	B-NP	O
PPX	PPX	NN	I-NP	B-protein
:	:	:	O	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
**	**	SYM	I-NP	O
CODE	CODE	NN	I-NP	O
:	:	:	O	O
FULL	FULL	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Resume	Resume	VB	B-VP	O
all	all	DT	B-NP	O
your	your	PRP$	I-NP	O
normal	normal	JJ	I-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
doses	dose	NNS	I-NP	O
you	you	PRP	B-NP	O
were	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
new	new	JJ	I-NP	O
medication	medication	NN	I-NP	O
is	be	VBZ	B-VP	O
lasix	lasix	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
helps	help	VBZ	B-VP	O
remove	remove	VB	I-VP	O
excess	excess	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
body	body	NN	I-NP	O
.	.	.	O	O

Have	Have	VB	B-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
chemistries	chemistry	NNS	I-NP	O
checked	check	VBD	B-VP	O
-LRB-	-LRB-	NN	B-NP	O
potassium	potassium	NN	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Make	Make	VB	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Madina	Madina	NNP	I-NP	O
within	within	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Ask	Ask	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Slappy	Slappy	NNP	I-NP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
your	your	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
on	on	IN	B-PP	O
dofetilide	dofetilide	NN	B-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
sure	sure	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
your	your	PRP$	B-NP	O
``	``	``	I-NP	B-cell_type
QTc	QTc	NNP	I-NP	I-cell_type
''	''	''	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
heart	heart	NN	I-NP	O
function	function	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
long	long	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
metformin	metformin	NN	B-NP	B-DNA
+	+	SYM	I-NP	I-DNA
dofetilide	dofetilide	NN	B-NP	I-DNA
5	5	CD	I-NP	I-DNA
.	.	.	O	O

Your	Your	PRP$	B-NP	O
sugars	sugar	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
mildly	mildly	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
-LRB-	-LRB-	HYPH	B-NP	B-protein
190s	190s	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Have	Have	VB	B-VP	O
your	your	PRP$	B-NP	O
sugars	sugar	NNS	I-NP	O
checked	check	VBD	B-VP	O
as	as	IN	B-SBAR	O
meds	med	NNS	B-NP	O
adjusted	adjust	VBN	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpt	outpt	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
ECHO	ECHO	NNP	B-NP	O
-	-	HYPH	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Toner	Toner	NNP	I-NP	O
will	will	MD	B-VP	O
compare	compare	VB	I-VP	O
in-patient	in-patient	JJ	B-NP	O
ECHO	ECHO	NN	I-NP	O
and	and	CC	I-NP	O
priors	prior	NNS	I-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
interval	interval	JJ	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
valve	valve	NN	B-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O

when	when	WRB	B-ADVP	O
to	to	TO	B-VP	O
undergo	undergo	VB	I-VP	O
repair	repair	NN	B-NP	B-protein
vs.	vs.	IN	B-PP	I-protein
replacement	replacement	NN	B-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

optimize	optimize	VB	B-VP	O
medical	medical	JJ	B-NP	O
regimen	regimen	NN	I-NP	O
for	for	IN	B-PP	O
management	management	NN	B-NP	O
of	of	IN	B-PP	O
mitral	mitral	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
lasix	lasix	NN	B-NP	O
+	+	SYM	B-NP	O
consider	consider	VBP	B-VP	O
hydral	hydral	JJ	B-NP	O
+	+	JJ	I-NP	O
nitrates	nitrate	NNS	I-NP	O
for	for	IN	B-PP	O
afterload	afterload	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pt	pt	NN	I-NP	O
was	be	VBD	B-VP	O
told	tell	VBN	I-VP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
?	?	.	O	O

`	`	``	O	O
lupus	lupus	NN	B-NP	O
like	like	IN	B-PP	O
'	'	''	O	O
symptoms	symptom	NNS	B-NP	O
on	on	IN	B-PP	O
lisinopril	lisinopril	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

ACE-I	ACE-I	NN	B-NP	B-protein
would	would	MD	B-VP	O
be	be	VB	I-VP	O
best	best	RB	B-ADVP	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
can	can	MD	B-VP	O
tolerate	tolerate	VB	I-VP	O
this	this	DT	B-NP	O
No	No	DT	I-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
HELVESTON	HELVESTON	NNP	B-NP	O
,	,	,	O	O
BUFORD	BUFORD	NNP	B-NP	O
DARRIN	DARRIN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ZX77	ZX77	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
11/4/05	11/4/05	CD	I-NP	O
@	@	SYM	B-NP	O
02	02	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

